BTD rs397514359: Understanding Carrier Status
The rs397514359 variant is a specific change within the BTD gene that is associated with carrier status for biotinidase deficiency. This condition is an inherited metabolic disorder that affects how the body recycles the vitamin biotin.
What each genotype means
Typical biotinidase activity
This genotype represents the most common sequence found in the BTD gene. Individuals with this profile are not expected to have biotinidase deficiency related to this specific variant.
This is the most common genotype observed in the general population.
Biotinidase deficiency carrier
This genotype indicates you carry one copy of the variant associated with biotinidase deficiency. Carriers typically have sufficient enzyme activity to remain asymptomatic, but you should discuss this result with a genetic counselor or clinician to understand potential implications for family planning.
This genotype is rare in the general population, though frequencies can vary by ancestry.
Potential biotinidase deficiency
This genotype indicates you carry two copies of the variant, which is associated with biotinidase deficiency. This condition affects the body's ability to recycle biotin and may require clinical management; please consult with a metabolic specialist or your primary healthcare provider to discuss appropriate testing and care.
This genotype is very rare in the general population.
What is rs397514359?
The variant rs397514359 is a single nucleotide polymorphism (SNP) located within the BTD gene on chromosome 3. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is cataloged in public databases as a potential marker for biotinidase deficiency. Because it is a rare variant, it is not commonly found in the general population. When researchers study such variants, they look at how the change in the DNA sequence might alter the function of the resulting protein. For rs397514359, the focus is on whether this change impacts the body's ability to process biotin effectively. Understanding the location and nature of this variant helps scientists and clinicians better interpret genetic testing results, particularly for individuals undergoing screening for metabolic conditions.
The Role of the BTD Gene
The BTD gene provides the essential instructions for the body to produce an enzyme called biotinidase. This enzyme plays a critical role in metabolism by recycling biotin, a B vitamin that is vital for breaking down fats, proteins, and carbohydrates. Biotinidase works by removing biotin from proteins in the food we eat, allowing the vitamin to be reused by the body in its free state. When the BTD gene contains pathogenic variants, the production or function of the biotinidase enzyme can be reduced or completely eliminated. This leads to biotinidase deficiency, a condition where the body cannot effectively recycle biotin. Without sufficient free biotin, several other enzymes that rely on this vitamin cannot function properly, which can lead to various health challenges if left unmanaged.
Research and Evidence
Research into BTD variants is primarily focused on their role in biotinidase deficiency, which is inherited in an autosomal recessive pattern. This means that an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to experience the symptoms of the condition. Carriers, who have only one copy of a pathogenic variant, are generally asymptomatic because their single functional copy of the gene produces enough biotinidase for normal metabolic function. The evidence strength for specific variants like rs397514359 is often categorized based on clinical observations and functional studies. While some variants are well-documented as pathogenic, others are classified based on their potential to disrupt enzyme activity. It is important to note that genetic evidence is constantly evolving as more data is collected from clinical testing and population studies.
Interpreting Your Results
If you have received information about your status regarding rs397514359, it is important to understand what this means in a clinical context. Being identified as a carrier for a recessive condition does not typically cause health symptoms, but it is relevant for family planning and understanding your genetic makeup. This information cannot be used to diagnose a condition or predict specific health outcomes on its own. If you are concerned about your carrier status or have a family history of metabolic disorders, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor. They can help interpret your results in the context of your overall health and family history. Never make changes to your diet, supplements, or medical care based solely on a genetic report without professional guidance.
How common is this variant?
The rs397514359 variant is considered rare in the general population. Specific frequency data can vary significantly by ancestry and is best reviewed through large-scale databases like gnomAD.
Frequently asked questions
What is biotinidase deficiency?
Biotinidase deficiency is an inherited metabolic disorder where the body cannot recycle biotin. This can lead to symptoms like skin rashes, hair loss, and neurological issues if not treated with biotin supplements.
Does being a carrier mean I have the disease?
No, being a carrier for an autosomal recessive condition like biotinidase deficiency typically means you do not have the disease and do not show symptoms. You have one functional copy of the gene that provides enough enzyme activity for normal function.
Should I take biotin supplements if I am a carrier?
You should not start or change any supplement regimen based on your carrier status without consulting your doctor. A healthcare professional can determine if supplementation is necessary based on your clinical health, not just your genetic status.
How is biotinidase deficiency treated?
Biotinidase deficiency is typically managed through lifelong biotin supplementation. Early diagnosis, often through newborn screening, allows for timely treatment that can prevent the development of symptoms.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs397514359?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BTD
This variant is identified as a carrier mutation for biotinidase deficiency.
This variant is associated with carrier status for biotinidase deficiency.
Carrier variant associated with autosomal recessive biotinidase deficiency.
Carrier variant indicating predisposition to pass on autosomal recessive biotinidase deficiency.
Pathogenic missense variant causing biotinidase deficiency, a recessive metabolic disorder, making single-copy carriers important for reproductive genetic screening.